Wein Matthew

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Wein Matthew's trades of Metagenomi Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-10 2026-09-08
S Sale
38,629 -12.4%
115.27
US$1,467,566 		38,629 -12.4% 115.27 US$1,467,566
2026-06-10 2026-06-05
PlS Planned sale
59,013 +31.7%
271.46
US$1,450,089 		59,013 +31.7% 271.46 US$1,450,089
2026-03-09 2026-03-05
S Sale
26,955 -22.3%
447.00
US$1,421,203 		26,955 -22.3% 447.00 US$1,421,203
2025-12-08 2025-12-05
S Sale
199 -0.2%
1.77
US$353 		199 -0.2% 1.77 US$353
2025-12-01 2025-09-05
PlS Planned sale
199 -1.0%
1.81
US$360 		199 -1.0% 1.81 US$360
2025-06-09 2025-06-06
S Sale
199 -1.2%
1.75
US$348 		199 -1.2% 1.75 US$348
2025-03-07 2025-03-05
S Sale
930 -8.9%
1.87
US$1,744 		930 -8.9% 1.87 US$1,744